Bark-Lynn Lew
Overview
Explore the profile of Bark-Lynn Lew including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
92
Citations
415
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Kang D, Kwon S, Sim W, Lew B
Ann Dermatol
. 2024 Dec;
36(6):384-388.
PMID: 39623615
Background: Telogen effluvium (TE) is characterized by diffuse hair loss following stressful events such as childbirth, prolonged surgery or anesthesia, and severe febrile illnesses, as well as intentional or unintentional...
2.
Kim J, Lee S, Kang H, Lee Y, Kim D, Park H, et al.
Ann Dermatol
. 2024 Dec;
36(6):376-383.
PMID: 39623614
Background: Alopecia areata (AA) is characterized by hair loss on the scalp and body, significantly impacting patients' quality of life based on its severity. Objective: This study aims to identify...
3.
Lee Y, Lee Y, Kim M, Lew B, Kwon S
Ann Dermatol
. 2024 Sep;
36(5):326-328.
PMID: 39343761
No abstract available.
4.
Choi J, Park H, Kim S, Huh C, Kwon O, Lew B, et al.
Clin Exp Dermatol
. 2024 Sep;
49(12):1627-1632.
PMID: 39302756
Background: There is ongoing debate regarding the association between telogen effluvium (TE) and COVID-19, as well as COVID-19 vaccines. Objectives: To investigate the impact of the COVID-19 pandemic and vaccination...
5.
Kang D, Choi S, Lee Y, Kim M, Lew B, Kwon S
J Dermatolog Treat
. 2024 Sep;
35(1):2398768.
PMID: 39265567
Background: Although post-inflammatory hyperpigmentation (PIH) is a common adverse event following laser procedures, studies evaluating its risk remain limited. Objective: To analyze PIH risk after 532 nm Q-switched Nd:YAG laser...
6.
Choi S, Kim J, Kim S, Lee Y, Kim M, Lew B, et al.
Ann Dermatol
. 2024 Jul;
36(4):247-251.
PMID: 39082661
No abstract available.
7.
Jang Y, Lee S, Park D, Lee Y, Kim D, Park H, et al.
Ann Dermatol
. 2024 Jul;
36(4):236-246.
PMID: 39082660
Background: A set of criteria for severity classification is essential in alopecia areata (AA). Currently, no guidelines are universally accepted for defining AA severity. Objective: This study aimed to establish...
8.
Lee Y, Kim K, Lew B, Huh C, Kang H, Jang Y, et al.
Ann Dermatol
. 2024 Jul;
36(4):225-230.
PMID: 39082658
Background: Contact immunotherapy using diphenylcyclopropenone (DPCP) is a recommended treatment for severe alopecia areata (AA); however, few clinical factors are known, and few standardized application methods affecting therapeutic efficacy have...
9.
Lee Y, Kwon S, Lew B
Int J Dermatol
. 2024 Jul;
64(2):413-414.
PMID: 38965061
No abstract available.
10.
Seo H, Lew B, Lee Y, Son S, Park C, Park Y, et al.
J Allergy Clin Immunol
. 2024 Jun;
154(4):965-973.
PMID: 38944393
Background: Mesenchymal stem cells (MSCs) play important roles in therapeutic applications by regulating immune responses. Objective: We investigated the safety and efficacy of allogenic human bone marrow-derived clonal MSCs (hcMSCs)...